Complement: Classical and Lectin Pathways

The classical and lectin pathways of complement are major recognition systems of innate immunity that are found in mammals and other animal species. By means of several multimolecular proteases – C1, the mannan-binding lectin (MBL)–MBL-associated serine protease 2 (MBL–MASP-2) and the ficolin–MASP-2 complexes – each comprising a recognition protein and a protease component, they detect pathogens and other targets and thereby trigger proteolytic reactions. Both pathways converge to the formation of C3 convertase, a complex protease that cleaves C3, the central component of the complement system. Proteolytic cleavage of C3 generates a series of fragments and elicits various effector mechanisms, including inflammation and phagocytosis. These mechanisms contribute to the elimination of pathogenic microorganisms and altered host cells from blood and tissues and modulate the adaptive immune response.

Key Concepts:

  • C1q, MBL and ficolins are pattern-recognition molecules able to sense conserved motifs on pathogens and altered self-cells.
  • C1q is a major sensor of apoptotic cells and regulator of immune tolerance.
  • Proteolytic cleavage of C3 is pivotal for amplification of the complement response and labelling of the target particles.
  • Target recognition, proteolysis and complex formation generate conformational changes that underlie complement functioning.
  • Complement activation and activity are tightly regulated to avoid noxious side effects on normal host cells and tissues.

Keywords: altered self-cells clearance; innate immunity; inflammation; pathogens; pattern recognition; phagocytosis; proteolysis

Figure 1. Modular structures of the proteins of the classical and lectin pathways. The nomenclature and symbols used for protein modules are those defined by Bork and Bairoch (1995). ANA, anaphylatoxin; CP, complement control protein (CCP) module; CUB, module found in complement C1r/C1s, Uegf and bone morphogenetic protein; C345C, complement proteins C3/C4/C5 C-terminal module; EG, epidermal growth factor (EGF)-like module; FM, factor I/membrane attack complex proteins C6/C7 (FIMAC) module; LA, low-density lipoprotein receptor class A (LDLRA) module; LNK, linker module; MG, macroglobulin module; SR, scavenger receptor cysteine-rich (SRCR) module; Ser Pr, serine protease domain; TED, thioester-containing domain; VA, von Willebrand factor type A module. Heterotrimeric associations of gC1q modules (A, B and C) are found at the C-terminal end of the collagen stems of C1q. Homotrimeric associations of C-type lectin (CLECT) and fibrinogen-like (FBG) modules are found at the corresponding positions in mannan-binding lectin and the ficolins, respectively. Unlabelled portions of the molecules represent connecting segments or sequence areas with no known homology to other proteins. Areas of collagen-like structure are grey, and coiled-coil structures are shown in black. C1q is a hexamer, whereas mannan-binding lectin is present in serum under multiple oligomeric forms. L-Ficolin and M-ficolin are thought to be mainly tetramers, whereas H-ficolin forms higher oligomers. Arrows indicate peptide bonds cleaved on activation of proteolytic enzymes. In the case of C3 and C4, the only cleavage shown is that mediated by C3 convertase and C1s or MASP-2, respectively. The location of the internal thioester group of C3 and C4 is indicated. The relative sizes of the proteins are approximate.
Figure 2. Classical and lectin pathways of complement. Activation of the classical pathway is triggered by direct or antibody-dependent recognition of a microorganism by C1q, whereas the lectin pathway is initiated by interaction of mannan-binding lectin (MBL) or ficolins with arrays of carbohydrates at the surface of a microorganism. Proteins expressing proteolytic activity are shown in red and proteolytic cleavages are indicated by red arrows. Fragments C4b and C3b exhibiting a reactive thioester group are green, whereas small fragments generating inflammatory reactions are yellow. C1 inhibitor (C1 INH), a member of the serine protease inhibitor (serpin) family, controls both C1 activation and C1 proteolytic activity. Its reactivity towards MASP-1 and MASP-2 is also established. Factor I cleaves C4b and C3b, preventing formation of the convertases and generating C3b fragments endowed with important biological activities.
Figure 3. Crystal structure of the C1r catalytic domain in its resting zymogen state. The domain associates as a head-to-tail homodimer through interactions between the CCP1 module of one molecule and the serine protease (SP) domain of its counterpart. The residues at the catalytic sites (a.s.) and at the cleavage sites are shown. NA, NB and CA, CB indicate the N- and C-terminal ends of molecules A and B. Modified from Budayova-Spano et al. (2002).
Figure 4. C1 complex of complement. C1q, C1r and C1s are blue, red and green, respectively. Upon assembly of the complex, the extended C1s–C1r–C1r–C1s tetramer is supposed to fold into a compact structure entirely located inside the cone defined by the C1q stems. The catalytic regions of C1r (red) and C1s (dark green) responsible for C1 activation and proteolytic activity towards C4 and C2 lie on the lower part of the cone. The interaction regions of C1r (orange) and C1s (light green) mediate assembly of the C1s–C1r–C1r–C1s tetramer and its interaction with reactive lysine residues in the middle part of the C1q stems. Modified from Bally et al. (2009).
Figure 5. Crystal structures of human C3 and C3b. The structures are shown in ribbon representation. The colour coding and abbreviations for each C3 domain are the same as in Figure 1. The thioester moiety is shown as red spheres. Modified from Janssen et al. (2006) with permission from Nature Publishing Group.
close
 References
    Bally I, Rossi V, Lunardi T et al. (2009) Identification of the C1q-binding sites of human C1r and C1s: a refined three-dimensional model of the C1 complex of complement. Journal of Biological Chemistry 284: 19340–19348.
    Beinrohr L, Harmat V, Dobo J et al. (2007) C1 inhibitor serpin domain structure reveals the likely mechanism of heparin potentiation and conformational disease. Journal of Biological Chemistry 282: 21100–21109.
    Bork P and Bairoch A (1995) Extracellular protein modules: a proposed nomenclature. Trends in the Biochemical Sciences 20(suppl.): C03.
    Bos IG, Hack CE and Abrahams JP (2002) Structural and functional aspects of C1-inhibitor. Immunobiology 205: 518–533.
    Botto M (1998) C1q knock-out mice for the study of complement deficiency in autoimmune disease. Experimental and Clinical Immunogenetics 15: 231–234.
    Budayova-Spano M, Lacroix M, Thielens NM et al. (2002) The crystal structure of the zymogen catalytic domain of complement protease C1r reveals that a disruptive mechanical stress is required to trigger activation of the C1 complex. EMBO Journal 21: 231–239.
    Cooper NR (1985) The classical complement pathway: activation and regulation of the first complement component. Advances in Immunology 37: 151–216.
    Dodds AW, Ren XD, Willis AC and Law SKA (1996) The reaction mechanism of the internal thioester in the human complement component C4. Nature 379: 177–179.
    van den Elsen JM, Martin A, Wong V et al. (2002) X-ray crystal structure of the C4d fragment of human complement component C4. Journal of Molecular Biology 322: 1103–1115.
    Feinberg H, Uitdehaag JC, Davies JM et al. (2003) Crystal structure of the CUB1-EGF-CUB2 region of mannose-binding protein associated serine protease-2. EMBO Journal 22: 2348–2359.
    Gaboriaud C, Juanhuix J, Gruez A et al. (2003) The crystal structure of the globular head of component protein C1q provides a basis for its versatile recognition properties. Journal of Biological Chemistry 278: 46974–46982.
    Gaboriaud C, Rossi V, Bally I, Arlaud GJ and Fontecilla-Camps JC (2000) Crystal structure of the catalytic domain of human complement C1s: a serine protease with a handle. EMBO Journal 19: 1755–1765.
    Gaboriaud C, Thielens NM, Gregory LA et al. (2004) Structure and activation of the C1 complex of complement: unravelling the puzzle. Trends in Immunology 25: 368–373.
    Garlatti V, Belloy N, Martin L et al. (2007) Structural insights into the innate immune recognition specificities of L- and H-ficolins. The EMBO Journal 26: 623–633.
    Gregory LA, Thielens NM, Arlaud GJ, Fontecilla-Camps JC and Gaboriaud C (2003) X-ray structure of the Ca2+-binding interaction domain of C1s. Insights into the assembly of the C1 complex of complement. Journal of Biological Chemistry 278: 32157–32164.
    Gregory LA, Thielens NM, Matsushita M et al. (2004) The X-ray structure of human mannan-binding lectin-associated protein 19 (MAp19) and its interaction site with mannan-binding lectin and L-ficolin. Journal of Biological Chemistry 279: 29391–29397.
    Harmat V, Gál P, Kardos J et al. (2004) The structure of MBL-associated serine protease-2 reveals that identical substrate specificities of C1s and MASP-2 are realized through different sets of enzyme–substrate interactions. Journal of Molecular Biology 342: 1533–1546.
    Inal JM, Hui KM, Miot S et al. (2005) Complement C2 receptor inhibitor trispanning: a novel human complement inhibitory receptor. Journal of Immunology 174: 256–366.
    Janssen B, Christodoulidou A, McCarthy A, Lambris JD and Gros P (2006) Structure of C3b reveals conformational changes that underlie complement activity. Nature 444: 213–216.
    Janssen BJ, Huizinga EG, Raaijmakers HC et al. (2005) Structures of complement component C3 provide insights into the function and evolution of immunity. Nature 437: 505–511.
    Krishnan V, Xu Y, Macon K, Volanakis JE and Narayana SV (2007) The crystal structure of C2a, the catalytic fragment of classical pathway C3 and C5 convertase of human complement. Journal of Molecular Biology 367: 224–233.
    Krishnan V, Xu Y, Macon K, Volanakis JE and Narayana SV (2009) The structure of C2b, a fragment of complement component C2 produced during C3 convertase formation. Acta Crystallographica Section D 65: 266–274.
    Lacroix M, Dumestre-Pérard C, Schoehn G et al. (2009) Residue Lys57 in the collagen-like region of human L-ficolin and its counterpart Lys47 in H-ficolin play a key role in the interaction with the mannan-binding lectin-associated serine proteases and the collectin receptor calreticulin. Journal of Immunology 182: 456–465.
    Matsushita M and Fujita T (2001) Ficolins and the lectin complement pathway. Immunological Reviews 180: 78–85.
    Milder FJ, Raaijmakers HC, Vandeputte MD et al. (2006) Structure of complement component C2a: implications for convertase formation and substrate binding. Structure 14: 1587–1597.
    Morgan BP and Walport MJ (1991) Complement deficiency and disease. Immunology Today 12: 301–306.
    Munthe-Fog L, Hummelshoj T, Honoré C et al. (2009) Immunodeficiency associated with FCN3 mutation and ficolin-3 deficiency. New England Journal of Medicine 360: 2637–2644.
    Nagar B, Jones RG, Diefenbach RJ, Isenman DE and Rini JM (1998) X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2. Science 280: 1277–1281.
    Pflieger D, Przybylski C, Gonnet F et al. (2010) Analysis of human C1q by combined bottom-up and top-down mass spectrometry: detailed mapping of post-translational modifications and insights into the C1r/C1s binding sites. Molecular and Cellular Proteomics 9: 593–610.
    Selander B, Mårtensson U, Weintraub A et al. (2006) Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2. Journal of Clinical Investigation 116: 1425–1434.
    Stengaard-Pedersen K, Thiel S, Gadjeva M et al. (2003) Inherited deficiency of mannan-binding lectin-associated serine protease 2. New England Journal of Medicine 349: 554–560.
    Strang CJ, Siegel RC, Phillips ML, Poon PH and Schumaker VN (1982) Ultrastructure of the first component of human complement: electron microscopy of the crosslinked complex. Proceedings of the National Academy of Sciences of the USA 79: 586–590.
    Takahashi M, Ishida Y, Iwaki D et al. (2010) Essential role of mannose-binding lectin-associated serine protease-1 in activation of the complement factor D. Journal of Experimental Medicine 207: 29–37.
    Teillet F, Gaboriaud C, Lacroix M et al. (2008) Crystal structure of the CUB1-EGF-CUB2 domain of human MASP-1/3 and identification of its interaction sites with mannan-binding lectin and ficolins. Journal of Biological Chemistry 283: 25715–25724.
    Turner MW (1996) Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunology Today 17: 532–540.
 Further Reading
    Arlaud GJ, Volanakis JE, Thielens NM et al. (1998) The atypical serine proteases of the complement system. Advances in Immunology 69: 249–307.
    book Dodds AW and Day AJ (1993) "The phylogeny and evolution of the complement system". In: Whaley K, Loos M and Weiler JM (eds) Complement in Health and Disease, pp. 39–88. London: Kluwer Academic.
    Frank MM and Fries LF (1991) The role of complement in inflammation and phagocytosis. Immunology Today 12: 322–326.
    Fujita T (2002) Evolution of the lectin complement pathway and its role in innate immunity. Nature Reviews Immunology 2: 346–353.
    Garlatti V, Martin L, Lacroix M et al. (2010) Structural insights into the recognition properties of human ficolins. Journal of Innate Immunity 2: 17–23.
    Garred P, Honoré C, Ma YJ et al. (2010) The Genetics of Ficolins. Journal of Innate Immunity 2: 3–16.
    Gros P, Milder FJ and Janssen BJ (2008) Complement driven by conformational changes. Nature 8: 48–58.
    Holmskov U, Thiel S and Jensenius JC (2003) Collectins and ficolins: humoral lectins of the innate immune defense. Annual Review of Immunology 21: 547–578.
    Liszewski MK, Farries TC, Lublin DM, Rooney IA and Atkinson JP (1996) Control of the complement system. Advances in Immunology 61: 201–283.
    Morgan BP and Gasque P (1996) Expression of complement in the brain: role in health and disease. Immunology Today 17: 461–466.
    book Volanakis JE and Frank MM (eds) (1998) The Human Complement System in Health and Disease. New York: Marcel Dekker.
Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Arlaud, Gérard J, and Thielens, Nicole M(Sep 2010) Complement: Classical and Lectin Pathways. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1002/9780470015902.a0000510.pub3]